TP53 and neoplasm: Tumorigenic pathways (p53 pathway, etc.)and tumor immunity (antigen processing and presentation, etc.)displayed the higher activity in high CRNDE expression group versus low CRNDE expression group in TCGA dataset (Fig. 4A), which were proven in CGGC datasets (Fig. 4B).